Member of the Association of American Physicians
Albert B. Deisseroth mainly focuses on Immunology, Leukemia, Internal medicine, Molecular biology and Surgery. Albert B. Deisseroth has included themes like Haematopoiesis, Bioinformatics and Cell biology in his Immunology study. His Leukemia research incorporates elements of Myeloid, Creatinine and Immunophenotyping.
Internal medicine and Gastroenterology are commonly linked in his work. His Molecular biology research is multidisciplinary, incorporating perspectives in Genetics, Gene, DNA, Promoter and Reporter gene. Albert B. Deisseroth interconnects Pharmacotherapy, Toxicity, Multiple myeloma and Dosing in the investigation of issues within Surgery.
His primary areas of study are Molecular biology, Immunology, Internal medicine, Leukemia and Cancer research. His research integrates issues of Cell culture, Transcription, Gene, Genetics and Viral vector in his study of Molecular biology. His Internal medicine research integrates issues from Gastroenterology, Surgery and Oncology.
His biological study focuses on Myelogenous. His Cancer research research incorporates elements of Chemoprotection and Genetic enhancement. His Bone marrow study incorporates themes from Haematopoiesis and Transplantation.
His primary scientific interests are in Immunology, Viral vector, Immune system, Antigen and CD40. Albert B. Deisseroth frequently studies issues relating to Cancer and Immunology. His Cancer study introduces a deeper knowledge of Internal medicine.
His Viral vector study combines topics from a wide range of disciplines, such as Adenoviridae, Cytosine deaminase, Genetic enhancement, Cancer cell and Molecular biology. The Molecular biology study combines topics in areas such as Transcription, Regulation of gene expression, Gene and Transduction. His Lymphocyte research focuses on Total body irradiation and how it relates to Bone marrow.
His primary areas of investigation include Viral vector, Immunology, Molecular biology, Cytotoxic T cell and Immunotherapy. His research integrates issues of Cytosine deaminase, Chemotherapy, Antimetabolite, Cancer cell and Combination therapy in his study of Viral vector. His study in Immunology is interdisciplinary in nature, drawing from both Vector, Clinical trial and Intensive care medicine.
The various areas that Albert B. Deisseroth examines in his Molecular biology study include Immunohistochemistry and Pathology. His Immunotherapy study integrates concerns from other disciplines, such as Cancer research, Antigen and CD40. His work in Melanoma addresses issues such as Oncology, which are connected to fields such as Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.
Albert B. Deisseroth;Zhifei Zu;David Claxton;Elie G. Hanania.
Blood (1994)
Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts
M Korbling;D Przepiorka;YO Huh;H Engel.
Blood (1995)
Chronic myelogenous leukemia: a concise update
H. M. Kantarjian;A. Deisseroth;R. Kurzrock;Z. Estrov.
Blood (1993)
Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy
John S. Gottdiener;Frederick R. Appelbaum;Victor J. Ferrans;Albert Deisseroth.
JAMA Internal Medicine (1981)
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
S. Giralt;J. Hester;Yang O Huh;Cheryl F Hirsch-Ginsberg.
Blood (1995)
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Martin Korbling;Yang O Huh;A. Durett;N. Mirza.
Blood (1995)
Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma
Frederick R. Appelbaum;Geoffrey P. Herzig;John L. Ziegler;Robert G. Graw.
Blood (1978)
A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter.
S. H. Sims;Ying Cha;M. F. Romine;Pei-Qing Gao.
Molecular and Cellular Biology (1993)
Considerations in the development of circulating tumor cell technology for clinical use
David R Parkinson;Nicholas Dracopoli;Brenda Gumbs Petty;Carolyn Compton.
Journal of Translational Medicine (2012)
Localization of the human α-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay
Albert Deisseroth;Arthur Nienhuis;Patricia Turner;Ramon Velez.
Cell (1977)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of Michigan–Ann Arbor
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Wake Forest University
The University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center
University of Washington
Technical University of Denmark
University of Palermo
TU Wien
Deakin University
Museu Paraense Emílio Goeldi
Landcare Research
Boston University
University of Alberta
Johns Hopkins University Applied Physics Laboratory
University of Maine
John Jay College of Criminal Justice
Harvard University
University of Helsinki
University of Washington
University of Pittsburgh
Princeton University